Sara Rodríguez - Concepedia

Author

Sara Rodríguez

Also Known As

Ibai Goicoechea, Rodriguez, S., S. Castaño Rodríguez, S. Gallego Rodríguez, S. Rodriguez, Sara Castaño Rodríguez, Sara Rodriguez, Sara Rodríguez

Publications

1.5K

Citations

H-Index

Concepts

All Affiliations

Clinica Universidad de Navarra Centro de Investigación Biomédica en Red de Cáncer Universidad de Salamanca Instituto de Investigación Biomédica de Salamanca Centro de Investigación del Cáncer

About

Sara Rodríguez is an author at Clinica Universidad de Navarra.

Sara Rodríguez

Publications

1.4K

Citations

H-Index

Page 1

	Year	Citations
Bruton Tyrosine Kinase Inhibitor Ibrutinib (PCI-32765) Has Significant Activity in Patients With Relapsed/Refractory B-Cell Malignancies Ranjana H. Advani, Joseph J. Buggy, Jeff P. Sharman, Journal of Clinical Oncology	2012	1.1K
Deep MRD profiling defines outcome and unveils different modes of treatment resistance in standard- and high-risk myeloma Ibai Goicoechea, Noemí Puig, María‐Teresa Cedena, Blood	2020	127
Circulating Tumor and Immune Cells for Minimally Invasive Risk Stratification of Smoldering Multiple Myeloma Rosalinda Termini, David Žihala, Evangelos Terpos, Clinical Cancer Research	2022	46
The Bruton's Tyrosine Kinase Inhibitor PCI-32765 Is Highly Active As Single-Agent Therapy in Previously-Treated Mantle Cell Lymphoma (MCL): Preliminary Results of a Phase II Trial Lühua Wang, Peter Martin, Kristie A. Blum, Blood	2011	41
Preneoplastic somatic mutations including <i>MYD88</i> <sup>L265P</sup> in lymphoplasmacytic lymphoma Sara Rodríguez, Jon Celay, Ibai Goicoechea, Science Advances	2022	39
Large T cell clones expressing immune checkpoints increase during multiple myeloma evolution and predict treatment resistance Cirino Botta, Cristina Pérez, Marta Larráyoz, Nature Communications	2023	29
Tumor cells in light-chain amyloidosis and myeloma show distinct transcriptional rewiring of normal plasma cell development Daniel Alameda, Ibai Goicoechea, Marco Vicari, Blood	2021	25
Single-Cell Characterization of the Multiple Myeloma (MM) Immune Microenvironment Identifies CD27-Negative T Cells As Potential Source of Tumor-Reactive Lymphocytes Cirino Botta, Cristina Pérez Ruiz, Ibai Goicoechea, Blood	2019	11

Page 1